E-LIB Suche - Ergebnisse für: Jason Melear

1

CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB ..:

Nassiri, Farshad ; Patil, Vikas ; Yefet, Leeor...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v65-v66 , 2023

Link: https://doi.org/10.1093/..

2

Dose escalation and expansion cohorts in patients with adva..:

Coombes, R. C. ; Howell, Sacha ; Lord, Simon R....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

3

Author Correction: Dose escalation and expansion cohorts in..:

Coombes, R. C. ; Howell, Sacha ; Lord, Simon R....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DAC..:

Yasenchak, Chris ; Flinn, Ian W. ; Melear, Jason...
HemaSphere. 7 (2023) S3 - p. e5881312 , 2023

Link: https://doi.org/10.1097/..

5

Daratumumab, cyclophosphamide, bortezomib, and dexamethason..:

Yimer, Habte ; Melear, Jason ; Faber, Edward...
Leukemia & Lymphoma. 63 (2022) 10 - p. 2383-2392 , 2022

Link: https://doi.org/10.1080/..

6

P-206: SELECT Trial in Progress: an open-label, phase 2 stu..:

Moreau, Philippe ; Delimpasi, Sosana ; Katodritou, Eirini...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S152 , 2021

Link: https://doi.org/10.1016/..

7

CLL-076: Phase 3b Study to Evaluate Debulking Regimens Prio..:

Sharman, Jeff ; Andorsky, David ; Melear, Jason...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S219-S220 , 2020

Link: https://doi.org/10.1016/..

8

Daratumumab, bortezomib, cyclophosphamide and dexamethasone..:

Yimer, Habte ; Melear, Jason ; Faber, Edward...
British Journal of Haematology. 185 (2019) 3 - p. 492-502 , 2019

Link: https://doi.org/10.1111/..

9

CMET-30. LEPTOMENINGEAL METASTASES: OUTCOMES WITH AGGRESSIV..:

Smith, Rachel ; Boman, Christina ; Thatikonda, Srivani...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi45-vi45 , 2017

Link: https://doi.org/10.1093/..

10

A phase 3b study of venetoclax and azacitidine or decitabin..:

Manda, Sudhir ; Anz III, Bertrand M. ; Benton, Christopher...
Hematological Oncology. 42 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

11

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurr..:

Nassiri, Farshad ; Patil, Vikas ; Yefet, Leeor S....
Nature Medicine. 29 (2023) 6 - p. 1370-1378 , 2023

Link: https://doi.org/10.1038/..

12

Zanubrutinib in patients with treatment‐naïve or relapsed/r..:

Castillo, Jorge J ; Kingsley, Edwin C ; Narang, Mohit...
eJHaem. 4 (2023) 1 - p. 301-304 , 2023

Link: https://doi.org/10.1002/..

13

IBCL-081 MAGNIFY Phase 3b Study of Lenalidomide + Rituximab..:

Lansigan, Frederick ; Andorsky, David Jacob ; Coleman, Morton...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S384 , 2022

Link: https://doi.org/10.1016/..

14

Phase 1/2 study of acalabrutinib and the PI3K delta inhibit..:

Barr, Paul M. ; Smith, Stephen D. ; Roschewski, Mark J....
Leukemia & Lymphoma. 63 (2022) 7 - p. 1728-1732 , 2022

Link: https://doi.org/10.1080/..

15

A phase 1b study evaluating the safety and preliminary effi..:

Plummer, Ruth ; Dean, Emma ; Arkenau, Hendrik-Tobias...
Lung Cancer. 163 (2022) - p. 19-26 , 2022

Link: https://doi.org/10.1016/..